Metabolic vulnerabilities open new therapeutic possibilities in clear cell renal cell carcinoma
Peer-Reviewed Publication
Updates every hour. Last Updated: 27-Oct-2026 09:16 ET (27-Oct-2026 13:16 GMT/UTC)
Clear cell renal cell carcinoma (ccRCC), the most common subtype of kidney cancer, is increasingly understood as a malignancy shaped by profound changes in cellular metabolism. A comprehensive review published in Genes & Diseases highlights how these metabolic alterations contribute to tumour growth, immune evasion and treatment resistance, while revealing potential opportunities for new therapeutic approaches.
The COVID-19 pandemic created unprecedented challenges for health professionals around the world. A new study published in the journal Nursing Inquiry describes violence that nurses and midwives in Latin America endured—not only physical aggression, but also ethical and emotional harm.
A review published in Genes & Diseases highlights the complex interplay between protein arginine methylation and ubiquitination, two forms of protein modification that can profoundly influence cancer development, progression and treatment response. The article brings together current understanding of how these interconnected molecular processes regulate proteins involved in cancer and identifies opportunities for future therapeutic approaches.
NYU Langone Orthopedics has appointed three leaders in sports medicine to head key orthopedic centers, including a new center that treats knee injuries causing pain and deterioration. Sabrina M. Strickland, MD, who will lead the new Center for Patellofemoral Disorders, Andreas H. Gomoll, MD, who will co-direct the Knee Preservation Center, and F. Winston Gwathmey, MD, who will direct the Hip Preservation and Hip Arthroscopy Center, will start on October 1.
Triple-negative breast cancer (TNBC) remains one of the most challenging forms of breast cancer to treat because it lacks the estrogen, progesterone and HER2 receptors that enable targeted treatment in other breast cancer subtypes. A review published in Genes & Diseases examines how targeting the epidermal growth factor receptor (EGFR) alongside other molecular targets, supported by nanocarrier-based delivery, could offer new possibilities for more precise TNBC treatment.
Millions of U.S. workers are exposed to hazardous airborne dust while on the job. They need regular chest X-rays to monitor their health because inhaling this dust can cause permanent lung damage.
Right now, the U.S. has only 200 physicians who are certified to read X-rays for dust-related disease, which is not enough.
MSU researchers have developed an artificial intelligence system to assist with more timely and accurate interpretation of X-ray images.China’s agriculture has long faced three major problems: excessive chemical fertilizer application, residual mulch film pollution, and low utilization rates of livestock and poultry manure. Excessive fertilizer input leads to soil acidification and compaction, and nutrient use efficiency continues to decline. Traditional polyethylene (PE) mulch film is difficult to degrade, and its year-by-year accumulation forms microplastic pollution, damaging soil microbial communities and arable land health. At the same time, livestock waste such as cow manure is large in volume and widely distributed, but its resource utilization pathways are limited, and crop-livestock cycling is not smooth. The green transformation of agriculture urgently needs integrated technologies that simultaneously ensure stable yields, reduce fertilizer use, reduce plastic pollution, and improve soil fertility.
A recent study in the Journal of Nutrition Education and Behavior (JNEB), published by Elsevier, provides new insight into how women with polycystic ovary syndrome (PCOS) adopt and maintain healthy eating and physical activity behaviors. Researchers found that behavior change is a nonlinear process shaped by factors that can either support progress or lead to disengagement.
A phase 1 clinical trial led by investigators at Mass General Brigham Cancer Institute and the University of Chicago Medicine Comprehensive Cancer Center has found that an investigational CAR-T therapy can lead to deep and durable responses in people with relapsed/refractory multiple myeloma. Results are published in The New England Journal of Medicine.